🇺🇸 FDA
Pipeline program

AZD0780

D7960C00012

Phase 3 small_molecule active

Quick answer

AZD0780 for Cardiovascular Disease is a Phase 3 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).

Program details

Company
AstraZeneca
Indication
Cardiovascular Disease
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials